Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Eris Lifesciences Ltd.
₹1,364
Invest in ERIS with up to 2.86x margin.
Trade with MTF₹1327.20
₹1376.20
₹1236.00
₹1910.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 315.29 | 650.50 | 578.64 | 404.77 | 399.73 |
| Operating Expense | 237.94 | 353.62 | 362.32 | 283.80 | 300.16 |
| Operating Profit | 77.35 | 296.88 | 216.32 | 120.97 | 99.57 |
| Depreciation | 38.66 | 39.30 | 37.60 | 43.38 | 46.68 |
| Interest | 45.20 | 46.50 | 45.14 | 53.16 | 54.65 |
| Tax | 0.80 | 85.10 | 56.27 | 10.71 | 4.25 |
| Net Profit | 3.09 | 149.57 | 99.99 | 30.47 | 1.78 |
Research Type
Equity , Long Term
Buy Range
₹1,574 - ₹0
Target Price
₹1,810
Stop Loss
-
Target Date
13 Nov 26
Potential Returns
14.99 %
₹1364.00
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 54.9 | 54.9 | 54.8 | 54.8 | 54.8 | 54.8 |
| FII | 8 | 8.4 | 8.4 | 8.4 | 7.2 | 6.8 |
| DII | 18.6 | 18 | 18.1 | 18.2 | 19.4 | 20.4 |
| Public | 18.5 | 18.7 | 18.6 | 18.6 | 18.6 | 18 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 31.85 K | 61.34 K | 51.92% |
| Week | 25.87 K | 50.4 K | 51.32% |
| 1 Month | 74.43 K | 1.05 L | 71.21% |
| 6 Month | 54 K | 1.18 L | 45.60% |
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 13 Feb, 2025 | 7.35 | INTERIM | 13 Feb, 2025 | Equity Share |
| 11 Aug, 2022 | 7.35 | INTERIM | 16 Aug, 2022 | Equity Share |
| 05 Aug, 2021 | 6.01 | INTERIM | 06 Aug, 2021 | Equity Share |
| 13 Aug, 2020 | 5.5 | INTERIM | 14 Aug, 2020 | Equity Share |
| 19 Mar, 2020 | 2.87 | INTERIM | 20 Mar, 2020 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,565 | ₹613.90 | ₹864 | ₹1,370 | ₹4,550 | ₹492.20 |
| % Change | 0.66% | -0.35% | 8.20% | 1.97% | 1.57% | -2.52% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 68.60 | 784.40 | 43.80 | 24.30 |
| 1 Year Return | 47.07 | 3.42 | 76.54 | -11.44 | -6.21 | 10.23 |
| ROCE | 30.24 | 34.78 | 34.76 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 370.00
-1.20%
Concord Biotech Ltd.
₹ 1059.00
+0.88%
Aarti Pharmalabs Ltd.
₹ 679.00
-1.34%
Piramal Pharma Ltd.
₹ 143.50
-0.19%
Supriya Lifescience Ltd.
₹ 626.70
-1.61%
Acutaas Chemicals Ltd.
₹ 2339.80
+0.17%
Alivus Life Sciences Ltd.
₹ 1040.55
-0.35%
Cohance Lifesciences Ltd.
₹ 320.00
+3.39%
Syngene International Ltd.
₹ 394.50
-1.14%
Alembic Pharmaceuticals Ltd.
₹ 720.00
-0.86%
Strides Pharma Science Ltd.
₹ 995.00
+3.17%
Granules India Ltd.
₹ 634.20
-1.57%
FDC Ltd.
₹ 341.50
-1.26%
Shilpa Medicare Ltd.
₹ 418.65
+3.70%
Jubilant Pharmova Ltd.
₹ 871.85
-0.67%
Natco Pharma Ltd.
₹ 1127.00
+1.31%
Caplin Point Laboratories Ltd.
₹ 1659.90
-0.02%
Neuland Laboratories Ltd.
₹ 14726.00
+4.77%
Marksans Pharma Ltd.
₹ 174.90
+0.17%
AstraZeneca Pharma India Ltd.
₹ 8050.00
+2.03%
Sanofi India Ltd.
₹ 3450.00
+0.89%
Procter & Gamble Health Ltd.
₹ 4800.00
-0.90%
Jeena Sikho Lifecare Ltd.
₹ 650.70
-0.75%
By signing up I certify terms, conditions & privacy policy